Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Tonix Pharmaceuticals Holding Corp

+ Add to Watchlist

TNXP:US

5.9500 USD 0.0500 0.83%

As of 20:10:00 ET on 02/27/2015.

Snapshot for Tonix Pharmaceuticals Holding Corp (TNXP)

Open: 6.0400 Day's Range: 5.8700 - 6.1060 Volume: 65,122
Previous Close: 6.0000 52wk Range: 5.3300 - 15.2089 1-Yr Rtn: -56.35%

Stock Chart for TNXP

No chart data available.
  • TNXP:US 5.9500
  • 1D
  • 1M
  • 1Y
6.0000
Interactive TNXP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TNXP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.6400
Est. EPS (USD) (12/2014) -2.6700
Est. PEG Ratio -
Market Cap (M USD) 96.02
Shares Outstanding (M) 16.14
30 Day Average Volume 149,351
Price/Book (mrq) 1.4589
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TNXP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TNXP

Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company that develops therapies for disorders of the central nervous system ("CNS"). The Company develops therapies for disorders that include fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"),

Seth LedermanChairman/President/CEO/FounderLeland J GershellCFO/Treasurer
Bruce L DaughertyChief Scientific OfficerGregory M SullivanChief Medical Officer
More Company Profile & Key Executives for TNXP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil